Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer

Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer

(2021) Alfredo Addeo et al.   CANCER CELL

Seroconversion rates following COVID-19 vaccination among patients with cancer

(2021) Astha Thakkar et al.   CANCER CELL

Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies

(2021) Lee M. Greenberger et al.   CANCER CELL

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies

(2021) Lee M. Greenberger et al.   CANCER CELL

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients

(2021) Victoria G. Hall et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of the BNT162b2mRNA Covid-19 Vaccine in Patients with Hematological Neoplasms

(2021) Moshe Mittelman et al.   BLOOD

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

(2021) Noam Barda et al.   LANCET

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

(2021) Einav G. Levin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

(2020) Vikas Mehta et al.   Cancer Discovery